These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 1677434
1. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene. Mickisch GH, Merlino GT, Aiken PM, Gottesman MM, Pastan I. J Urol; 1991 Aug; 146(2):447-53. PubMed ID: 1677434 [Abstract] [Full Text] [Related]
2. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity. Mickisch GH, Licht T, Merlino GT, Gottesman MM, Pastan I. Cancer Res; 1991 Oct 01; 51(19):5417-24. PubMed ID: 1680550 [Abstract] [Full Text] [Related]
5. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. Park JG, Lee SK, Hong IG, Kim HS, Lim KH, Choe KJ, Kim WH, Kim YI, Tsuruo T, Gottesman MM. J Natl Cancer Inst; 1994 May 04; 86(9):700-5. PubMed ID: 7908989 [Abstract] [Full Text] [Related]
6. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. Zacherl J, Hamilton G, Thalhammer T, Riegler M, Cosentini EP, Ellinger A, Bischof G, Schweitzer M, Teleky B, Koperna T. Cancer Chemother Pharmacol; 1994 May 04; 34(2):125-32. PubMed ID: 7910786 [Abstract] [Full Text] [Related]
7. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. Chaudhary PM, Roninson IB. J Natl Cancer Inst; 1993 Apr 21; 85(8):632-9. PubMed ID: 8096875 [Abstract] [Full Text] [Related]
9. Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer. Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnert M, Roe DJ, Miller TP. Blood; 1991 Jul 01; 78(1):44-50. PubMed ID: 1676918 [Abstract] [Full Text] [Related]
10. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. Horio M, Lovelace E, Pastan I, Gottesman MM. Biochim Biophys Acta; 1991 Jan 09; 1061(1):106-10. PubMed ID: 1671642 [Abstract] [Full Text] [Related]
13. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine. Speicher LA, Barone LR, Chapman AE, Hudes GR, Laing N, Smith CD, Tew KD. J Natl Cancer Inst; 1994 May 04; 86(9):688-94. PubMed ID: 7908988 [Abstract] [Full Text] [Related]
14. Clinical reversal of drug resistance. Goldstein LJ. Curr Probl Cancer; 1995 May 04; 19(2):65-124. PubMed ID: 7600845 [Abstract] [Full Text] [Related]
19. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice. Mickisch GH, Pai LH, Gottesman MM, Pastan I. Cancer Res; 1992 Aug 15; 52(16):4427-32. PubMed ID: 1353705 [Abstract] [Full Text] [Related]
20. Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma. Mickisch GH, Noordzij MA, vd Gaast A, Gebreamlack P, Köhrmann KU, Mogler-Drautz E, Kupper H, Schröder FH. J Cancer Res Clin Oncol; 1995 Aug 15; 121 Suppl 3():R11-6. PubMed ID: 8698736 [Abstract] [Full Text] [Related] Page: [Next] [New Search]